Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003882 · ClinicalTrials.gov registry record
Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting
A clinical trial, sponsored by Radicle Science.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT05003882 is a clinical trial that has completed, run by Radicle Science. The registered enrollment target is 3,000 participants.
The verdict
NCT05003882 has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
A randomized, open-label study of commercially available, orally ingestible, Cannabidiol (CBD) products used in the real-world setting for pain, sleep, and anxiety.
Interventions
- OTHER Commercially available, orally ingestible CBD product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05003882
The ClinicalTrials.gov registry entry for NCT05003882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radicle Science, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Commercially available, orally ingestible CBD product is the first listed.
NCT05003882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05003882 about?
NCT05003882 is a clinical study titled "Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting". A randomized, open-label study of commercially available, orally ingestible, Cannabidiol (CBD) products used in the real-world setting for pain, sleep, and anxiety.
What is the current status of trial NCT05003882?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2021-08-02. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT05003882?
The interventions under investigation include: Commercially available, orally ingestible CBD product (OTHER).
Who is sponsoring clinical trial NCT05003882?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.